ELVN FY 2019 Earnings — Enliven Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ELVNEnliven Therapeutics, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$33,000

Operating Income

-$24M

Net Income

-$23M

EPS (Diluted)

$-5.43

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$899,000

Balance Sheet

Total Assets

$33M

Total Liabilities

$4M

Stockholders' Equity

-$49M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$33,000	$0	—
Operating Income	-$24M	-$11M	-125.9%
Net Income	-$23M	-$11M	-107.0%